![De Novo Therapy with Everolimus and Low-Dose Calcineurin Inhibitors in Kidney Transplantation | Semantic Scholar De Novo Therapy with Everolimus and Low-Dose Calcineurin Inhibitors in Kidney Transplantation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/030db632fd1622c9fb92aa16bffd5197cb35b7fe/8-Figure2-1.png)
De Novo Therapy with Everolimus and Low-Dose Calcineurin Inhibitors in Kidney Transplantation | Semantic Scholar
![Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2013251417300883-gr1.jpg)
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities - ScienceDirect
![Initial dose and dose adjustments of everolimus and axitinib as second... | Download Scientific Diagram Initial dose and dose adjustments of everolimus and axitinib as second... | Download Scientific Diagram](https://www.researchgate.net/publication/286766440/figure/tbl1/AS:669110786600982@1536539851854/Initial-dose-and-dose-adjustments-of-everolimus-and-axitinib-as-second-targeted-therapy.png)
Initial dose and dose adjustments of everolimus and axitinib as second... | Download Scientific Diagram
![Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2013251417300883:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92lL8PRnKGMnsiVXV6EVJ5QRkjJZIKj2umwUyY+cL6K8cyMCoG0zLrx/ORKa7YTjKUFV05yVJIH/ZJ7/flQB1eTMrqzaTDYNJI1H3lyttyunA+GbiPUmXx7sXPO9Mv7sH3iE4MKKWC/FO6IoDweG3lWqGYxIgshRz6RbAC1a56prqbHf6JBOLbpFZE9n2ff+TwrIH8+f1UYf4CrjGhERlSvIZAxl4YXAoF7UYBfuS01uCfYZkXPkCiPJLDSvXV2ik3MpVWpoSq+1uq7leDx2TQn9fKu3PLPgsQCcV8Iq0YxE)
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities | Nefrología
![Recommendations of everolimus use in liver transplant | Gastroenterología y Hepatología (English Edition) Recommendations of everolimus use in liver transplant | Gastroenterología y Hepatología (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S244438241730158X:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNcRcp7AE8pxI7/lU7i5mKGl6o67DY/uL2+/IxZemV5MIqAjD3SWPjrFs2sOZiACxejbMkZu4oEPV0J6NaokwpWiG1nFpaRDyRli2l1herxyVsGMCRD2jAEjD7WF63r5Bu8tVTWLElZku03XssFmwWRcagaTB+vwnOJCxlMbkAwWymUei3llIz6ql6R1j81pNiu4BVKyUdRvMTpJCvzbFqRXdbEa3obE3+rF6VO0Dx/vZ3HE3gjSciV3k4wxzv+1Wu0=)
Recommendations of everolimus use in liver transplant | Gastroenterología y Hepatología (English Edition)
![Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer](https://larvolclin.s3.us-west-2.amazonaws.com/16675465114542993196364bd8f878e2.jpeg)
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
![IJMS | Free Full-Text | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients IJMS | Free Full-Text | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients](https://pub.mdpi-res.com/ijms/ijms-19-00882/article_deploy/html/images/ijms-19-00882-ag.png?1569941125)
IJMS | Free Full-Text | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
![Frontiers | Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex Frontiers | Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex](https://www.frontiersin.org/files/Articles/744050/fmed-08-744050-HTML/image_m/fmed-08-744050-g001.jpg)
Frontiers | Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
![Progression-free survival, (a) by everolimus dose. Progression-free... | Download Scientific Diagram Progression-free survival, (a) by everolimus dose. Progression-free... | Download Scientific Diagram](https://www.researchgate.net/publication/338960099/figure/fig3/AS:864813265727491@1583198958336/Progression-free-survival-a-by-everolimus-dose-Progression-free-survival-b-by.jpg)
Progression-free survival, (a) by everolimus dose. Progression-free... | Download Scientific Diagram
![Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy | Breast Cancer Research | Full Text Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-021-01394-y/MediaObjects/13058_2021_1394_Fig2_HTML.png)
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy | Breast Cancer Research | Full Text
![These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral useInitial U.S. Approval: 2009 These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral useInitial U.S. Approval: 2009](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-01.jpg&id=598237)